We subsequently probed the CSF of MS patients for cytokines and chemokines and found that CXCL13 concentration was the most consistently elevated protein relative to symptomatic controls (SC), as defined by Teunissen et al. [35], compared to 39 other cytokines and chemokines [29]. The gene discussed is CXCL13; the disease is myeloid sarcoma.